Skip to content

Improving upper limb movement after spinal cord injury with a wearable device

Investigating electrophysiological changes in triceps after paired stimulation from a wearable device in chronic spinal cord injury survivors

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN15025040
Enrollment
40
Registered
2021-07-07
Start date
2021-07-30
Completion date
Unknown
Last updated
2023-08-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic spinal cord injury Injury, Occupational Diseases, Poisoning Injury of spinal cord, level unspecified

Interventions

Subjects fulfilling the selection criteria will be randomized (via computer generated code) to one of the two equal size parallel arms of the study. Group A: Will first receive the wearable device (el
this produces a brief click with an intensity of 110 dB SPL. The earpiece is placed in the contralateral ear. An internal flash memory with plasticity stimulus protocol will be inserted under the cove

Sponsors

Newcastle University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Chronic (>1 year) cervical injury (C2-C7) 2. Male or female at least 18 years of age 3. Detectable EMG activity in triceps 4. Without upper limb fracture or subluxation/ dislocation of joints within last six months. 5. Be able to follow study instructions and perform study tasks. 6. Willing to provide written informed consent; if necessary through an independent witness should the subject be unable to write themselves due to their injury.

Exclusion criteria

Exclusion criteria: 1. Exhibit major medical problems or poor physical conditions that would interfere with participation, as reported by the participant. 2. Excessive pain in any joint that might limit examination. 3. Participants with contraindications for TMS as confirmed by ‘TMS Adult Safety Screen’ questionnaire (Keel et al. 2001).

Design outcomes

Primary

MeasureTime frame
Measured at baseline, after 4 and 8 weeks: 1. Electrophysiological changes in triceps muscle are measured using EMG 2. Motor evoked potential (MEP) size measured using transcranial magnetic brain stimulation 3. Maximal voluntary contraction measured using a force transducer and EMG 4. Reaction time measured using a StartReact paradigm 5. Reaching parameters such as speed and trajectory accuracy measured using a custom built planar reaching task 6. Upper extremity function measured using CUE questionnaire

Secondary

MeasureTime frame
1. Compliance (how long subjects use the device each day) using the device clock data and participants’ filled-up diary. 2. Adverse event profile among participants using our intervention device. 3. Range, speed and accuracy of upper limb movement (reaching task with Polhemus motion tracking system) before and after intervention 4. Maximum voluntary contraction force of elbow flexion and extension before and after intervention 5. Auditory startle response (StartReact paradigm) of triceps before and after intervention. This assay will examine the change of reticulospinal tract activity by the intervention (if any). 6. Auditory startle response (startle + TMS paradigm) of triceps before and after intervention. This assay will examine the change of reticulospinal tract activity by the intervention (if any). 7. Motor evoked potentials by transcranial magnetic stimulation (TMS with 2 different coil orientations) before and after intervention. This assay will examine the change of corticospinal tract activity by the intervention (if any).

Countries

England, United Kingdom

Contacts

Public ContactMaria Germann
m.germann2@newcastle.ac.uk+44 (0) 191 208 6977

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026